Aspects of Peptidomimetics - Peptide and Protein Design for Biopharmaceutical Applications - page 104

novel scaffolds, and has allowed the identification of a number of privi-
leged scaffolds which have proven to be highly successful for peptidomi-
metic design.
REFERENCES
[1] G. R. Marshall,A hierarchical approach to peptidomimetic design, Tetrahedron , 49,
3547-3558 (1993).
[2] V. J. Hruby and P. M. Balse, Conformational and topographical considerations in
designing agonist peptidomimetics from peptide leads, Curr.Med.Chem ., 7, 945-970
(2000).
[3] C. Adessi and C. Soto, Converting a peptide into a drug: Strategies to improve
stability and bioavailability, Curr.Med.Chem ., 9, 963-978 (2002).
[4] M. D. Fletcher and M. M. Campbell, Partially modified retro-inverso peptides:
development, synthesis, and conformational behavior, Chem.Rev ., 98, 763-795
(1998).
[5] G. J. Moore, Designing peptide mimetics, Trends Pharmacol.Sci ., 15, 124-129
(1994).
[6] A. S. Ripka and D. H. Rich, Peptidomimetic design, Curr.Opin.Chem.Biol ., 2, 441-452
(1998).
[7] M. Chorev, The partial retro-inverso modification: A road traveled together,
Biopolymers , 80, 67-84 (2005).
[8] Freidinger, R., Peptides and their retro enantiomers are topologically nonidentical,
personal communication.
[9] L. Scheibler and M. Chorev, Synthesis of Retro-Inverso-Peptides., In Methods
of Organic Chemistry (Houben-Weyl). Synthesis of Peptides and Peptidomimetics .,
4th edn., 2002, 528-551.
[10] H. Tamamura, M. Mizumoto, K. Hiramatsu, S. Kusano, S. Terakubo, N. Yamamoto,
J. O. Trent, Z. Wang, S. C. Peiper, H. Nakashima, A. Otaka and N. Fujii,
Topochemical exploration of potent compounds using retro-enantiomer libraries of
cyclic pentapeptides, Org.Biomol.Chem. , 2, 1255-1257 (2004).
[11] Y.-C. Chen, A. Muhlrad, A. Shteyer, M. Vidson, I. Bab and M. Chorev, Bioactive
pseudopeptidic analogues and cyclostereoisomers of osteogenic growth peptide
C-terminal pentapeptide, OGP(10-14), J.Med.Chem ., 45, 1624-1632 (2002).
[12] P. M. Fischer, The design, synthesis and application of stereochemical and directional
peptide isomers: A critical review, Curr.Prot.Pept.Sci ., 4, 339-356 (2003).
[13] M. Molteni, C. Pesenti, M. Sani, A. Volonterio and M. Zanda, Fluorinated peptido-
mimetics: synthesis, conformational and biological features, J.Fluorine Chem ., 125,
1735-1743 (2004).
[14] A. Volonterio, S. Bellosta, F. Bravin, M. C. Bellucci, L. Bruch´, G. Colombo,
L. Malpezzi, S. Mazzini, S. V. Meille, M. Meli, C. Ramirez de Arellano and
M. Zanda, Synthesis, structure and conformation of partially-modified retro- and
retro-inverso c[NHCH(CF3)]Gly peptides, Chem.Eur.J ., 9, 4510-4522 (2003).
[15] M. Zanda, Trifluoromethyl group: an effective xenobiotic function for peptide
backbone modification, New J.Chem ., 28, 1401-1411 (2004).